Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
May 02 04:00PM ET
55.15
Dollar change
-1.16
Percentage change
-2.06
%
IndexS&P 500 P/E9.69 EPS (ttm)5.69 Insider Own0.17% Shs Outstand1.29B Perf Week-18.09%
Market Cap69.40B Forward P/E6.75 EPS next Y8.17 Insider Trans-0.80% Shs Float1.26B Perf Month-26.07%
Income7.32B PEG2.62 EPS next Q1.91 Inst Own82.05% Short Float1.43% Perf Quarter-25.39%
Sales361.35B P/S0.19 EPS this Y-16.09% Inst Trans0.60% Short Ratio1.75 Perf Half Y-20.08%
Book/sh59.08 P/B0.93 EPS next Y11.46% ROA2.99% Short Interest18.00M Perf Year-24.20%
Cash/sh10.44 P/C5.28 EPS next 5Y3.69% ROE10.07% 52W Range54.00 - 83.25 Perf YTD-30.15%
Dividend Est.2.48 (4.49%) P/FCF8.53 EPS past 5Y- ROI4.97% 52W High-33.75% Beta0.57
Dividend TTM2.54 (4.61%) Quick Ratio0.61 Sales past 5Y13.36% Gross Margin14.95% 52W Low2.13% ATR (14)2.36
Dividend Ex-DateApr 19, 2024 Current Ratio0.81 EPS Y/Y TTM104.83% Oper. Margin4.35% RSI (14)12.10 Volatility3.02% 2.26%
Employees300000 Debt/Eq1.11 Sales Y/Y TTM9.11% Profit Margin2.03% Recom1.83 Target Price74.08
Option/ShortYes / Yes LT Debt/Eq0.99 EPS Q/Q-46.91% Payout38.34% Rel Volume3.67 Prev Close56.31
Sales Surprise-1.00% EPS Surprise-22.73% Sales Q/Q3.60% EarningsMay 01 BMO Avg Volume10.31M Price55.15
SMA20-20.27% SMA50-25.05% SMA200-24.01% Trades Volume37,862,787 Change-2.06%
Date Action Analyst Rating Change Price Target Change
TodayDowngrade UBS Buy → Neutral $85 → $60
May-01-24Downgrade Leerink Partners Outperform → Market Perform $87 → $60
May-01-24Downgrade Cantor Fitzgerald Overweight → Neutral
Mar-06-24Initiated Barclays Equal Weight $78
Feb-26-24Initiated Leerink Partners Outperform $88
Dec-22-23Initiated HSBC Securities Buy $94
Sep-19-23Upgrade Evercore ISI In-line → Outperform $81 → $83
Sep-12-23Upgrade Wolfe Research Peer Perform → Outperform $80
Aug-18-23Downgrade Edward Jones Buy → Hold
May-26-23Initiated Piper Sandler Overweight $85
Today 10:56AM
10:18AM
10:17AM
10:10AM
10:07AM
09:50AM Loading…
09:50AM
09:47AM
09:41AM
09:21AM
08:38AM
07:11AM
07:03AM
06:48AM
06:41AM
06:39AM
06:34AM Loading…
06:34AM
03:02AM
01:05AM
May-01-24 11:09PM
05:40PM
05:06PM
04:54PM
04:00PM
04:00PM
03:10PM
03:02PM
02:38PM
02:37PM
02:34PM
01:46PM
01:46PM Loading…
01:46PM
01:25PM
01:15PM
12:31PM
12:27PM
12:25PM
12:22PM
12:20PM
12:20PM
11:36AM
11:16AM
11:12AM
10:52AM
10:34AM
10:14AM
10:04AM
09:56AM
09:56AM
09:33AM
09:30AM
08:38AM
08:38AM
08:38AM
08:23AM
08:19AM
08:18AM
08:15AM
08:06AM
07:51AM
07:45AM
07:40AM
07:30AM
07:24AM
07:01AM
06:49AM
06:45AM
06:40AM
06:38AM
06:35AM
06:30AM
06:30AM
Apr-30-24 05:38PM
04:30PM
08:38AM
08:31AM
Apr-29-24 05:22PM
09:52AM
06:00AM
05:30AM
Apr-28-24 08:00AM
Apr-27-24 11:50AM
09:44AM
09:15AM
Apr-26-24 05:45PM
02:36PM
11:43AM
10:44AM
09:15AM
Apr-25-24 06:20PM
05:50PM
10:10AM
09:00AM
06:45AM
Apr-24-24 03:52PM
10:01AM
09:00AM
Apr-23-24 04:10PM
Apr-22-24 09:30AM
08:57AM
Apr-20-24 09:16AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mahoney Michael FDirectorMay 02 '24Buy54.499,181500,2949,356May 02 04:30 PM
LUDWIG EDWARD JDirectorMay 02 '24Buy53.881,00053,87921,630May 02 04:31 PM
Shah Prem SEVP and Pres-Pharm, Consumer WFeb 16 '24Sale76.9529,4732,267,94739,765Feb 16 06:46 PM
LUDWIG EDWARD JDirectorNov 03 '23Buy70.472,000140,93020,630Nov 06 10:59 AM
Clark James DavidSVP, Cont & Chief Acct OfficerAug 03 '23Sale74.9225,7591,930,0044,698Aug 04 05:41 PM
Lynch Karen SPresident and CEOMay 03 '23Buy69.7514,000976,567431,392May 05 08:27 AM